New York, NY -- (SBWIRE) -- 01/21/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: ZIOPHARM Oncology Inc (NASDAQ:ZIOP), GTx, Inc (NASDAQ:GTXI), WidePoint Corporation (NYSEMKT:WYY), Affymetrix, Inc (NASDAQ:AFFX)
ZIOPHARM Oncology Inc (NASDAQ:ZIOP) showed a volume of 1.77 million shares by the end of last trade whereas the average volume of the stock remained 1.35 million shares. The stock opened the session at $4.46 but then moved to $4.77. At that price, the stock showed a positive performance of 6.95%. ZIOPHARM Oncology, Inc., is a biotechnology company. The Company employs gene expression and control technology to deliver deoxyribonucleic acid (DNA) for the treatment of cancer. Will ZIOP Continue To Move Higher? Find Out Here
GTx, Inc (NASDAQ:GTXI) opened the session at $2.13 and closed the session at $2.11. The stock showed a negative performance of -0.94% in previous trading session. Traded with volume of 1.76million shares in the prior session and the average volume of the stock remained 916,154.00 shares. GTx, Inc. is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (SARMs) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions.
Has GTXI Found The Bottom And Ready To Gain Momentum? Find Out Here
WidePoint Corporation (NYSEMKT:WYY) opened the session at $1.93 and closed the session at $1.90. Traded with volume of 1.77 million shares in the prior session and the average volume of the stock remained 1.61 million shares. The beta of the stock remained 0.85. WidePoint Corporation (WidePoint) is a provider of customized technology-based products and solutions to both the government sector and commercial markets. The Company operates in three segments: Communications Management, Cybersecurity Solutions,
Is WYY a Solid Investment at These Levels? Read This Report For Details
Affymetrix, Inc (NASDAQ:AFFX) the stock decreased -2.32% and finished the session at $9.26. Traded with volume of 1.71 million shares in the prior session and the average volume of the stock remained 1.18 million shares. The beta of the stock remained 1.70. Affymetrix, Inc. (Affymetrix) is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets.
Will AFFX Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)